I Wodinsky
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Metal complexes synthesis and properties
-
- Cancer therapeutics and mechanisms
- Biochemical and Molecular Research
Papers in
-
- Cancer therapeutics and mechanisms 15
- Biochemical and Molecular Research 8
- Oncology 24
- Cancer Treatment and Pharmacology 11
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- David Kessel (6 shared papers)Thomas C. Hall (4 shared papers)Charles J. Kensler (17 shared papers)Jacob J. Clement (4 shared papers)John M. Venditti (7 shared papers)Randall K. Johnson (3 shared papers)Raphael Catane (1 shared paper)D W Yesair (5 shared papers)
- Journals
- Cryobiology (4 papers)Science (3 papers)Biochemical Pharmacology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Nature (3 papers)
- Partner nations
- United States
In The Last Decade
I Wodinsky
62 papers receiving 825 citations
Peers
Comparison fields: 5 of 93
- Oncology 324
- Molecular Biology 489
- Cancer Research 97
- Hematology 72
- Genetics 58
Countries citing papers authored by I Wodinsky
This map shows the geographic impact of I Wodinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Wodinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Wodinsky more than expected).
Fields of papers citing papers by I Wodinsky
This network shows the impact of papers produced by I Wodinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Wodinsky. The network helps show where I Wodinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside I Wodinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. | 1968 | 130 |
| 2 | 1967 | 102 | |
| 3 | Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. | 1980 | 88 |
| 4 | 1955 | 69 | |
| 5 | 1966 | 48 | |
| 6 | Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo. | 1974 | 46 |
| 7 | Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo. | 1980 | 31 |
| 8 | 1968 | 27 | |
| 9 | Studies on folic reductase. 3. The level of enzyme activity and response to methotrexate of transplantable mouse tumors. | 1965 | 27 |
| 10 | 1978 | 25 | |
| 11 | On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA. | 1968 | 24 |
| 12 | Activity of cytosine arabinoside (NSC-63878) in a spectrum of rodent tumors. | 1965 | 23 |
| 13 | 1968 | 17 | |
| 14 | Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective. | 1976 | 17 |
| 15 | 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series. | 1977 | 14 |
| 16 | Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors. | 1976 | 14 |
| 17 | Review of selected experimental brain tumor models used in chemotherapy experiments. | 1975 | 13 |
| 18 | 1970 | 12 | |
| 19 | 1965 | 11 | |
| 20 | Toxicology of anti-leukemic agents with special reference to phthalanilide derivatives. | 1965 | 11 |
About I Wodinsky
I Wodinsky is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Genetics, having authored 69 papers that have together received 979 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (11 papers), Biochemical and Molecular Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Synthesis and biological activity (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (324 citations), Molecular Biology (489 citations), Cancer Research (97 citations), Hematology (72 citations) and Genetics (58 citations). I Wodinsky has collaborated with scholars based in United States. Frequent co-authors include David Kessel, Thomas C. Hall, Charles J. Kensler, Jacob J. Clement, John M. Venditti, Randall K. Johnson, Raphael Catane, D W Yesair, Awtar Krishan and Ruth I. Geran. Their work appears in journals such as Cryobiology, Science, Biochemical Pharmacology, International Journal of Radiation Oncology*Biology*Physics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.